EXPRESS PUBLICATION
Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium
Onnik Agbulut, PhD* ,*,
Susanne Vandervelde*,
Nawwar Al Attar, MD*,
Jérôme Larghero, MD ,
Said Ghostine, MD ,
Bertrand Léobon, MD||||,
Estelle Robidel*,
Paolo Borsani, MD*,
Marc Le Lorc'h¶¶,
Alvine Bissery, PhD||,
Christine Chomienne, MD, PhD,
Patrick Bruneval, MD, PhD¶#,
Jean-Pierre Marolleau, MD,
Jean-Thomas Vilquin, PhD,
Albert Hagège, MD, PhD,
Jane-Lyse Samuel, PhD* and
Philippe Menasché, MD, PhD**
* Inserm U572, Hôpital Lariboisiére, Paris, France
Inserm U633, Hôpital Européen Georges Pompidou, Paris, France
Department of Cardiology, Hôpital Européen Georges Pompidou, Paris, France
|| Clinical Investigation Center 9201, Hôpital Européen Georges Pompidou, Paris, France
¶ Department of Pathology, Hôpital Européen Georges Pompidou, Paris, France
# Inserm U430, Hôpital Européen Georges Pompidou, Paris, France
** Department of Cardiovascular Surgery, Hôpital Européen Georges PompidouParis, France
Inserm E0003, Paris, France
Laboratory of Cell Therapy, Hôpital Saint-LouisParis, France
Inserm U582, Paris, France
|||| Assistance Publique-Hôpitaux de Paris, Ecole de Chirurgie; Paris, France
¶¶ Department of Cytogenetics, Hôpital Necker, Paris, France
Manuscript received February 16, 2004;
revised manuscript received March 26, 2004,
accepted March 30, 2004.
* Reprint requests and correspondence: Dr. Onnik Agbulut, Inserm U633, Laboratoire d'étude des greffes et prothèses car-diaques, 96, rue Didot, 75014, Paris, France.
onnik.agbulut{at}larib.inserm.fr
OBJECTIVES: The present study was designed as a face-to-face functional comparison of human skeletal myoblasts (SMs) and CD133+ bone marrow-derived hematopoietic progenitors in an animal model of semichronic myocardial infarction.
BACKGROUND: Compared with SMs, bone marrow-derived cells have the advantage of plasticity and might more effectively regenerate ischemic cardiac tissue. However, few data exist on the comparative efficacy of these two cell types in semichronic infarcts.
METHODS: A myocardial infarction was created by coronary ligation in 32 nude rats. Ten days later, rats received in-scar injections of human SMs, CD133+ progenitors, or culture medium. Left ventricular function was assessed before and one month after transplantation by echocardiography and pressure-volume loops. Immunofluorescence, polymerase chain reaction, and in situ hybridization were used to detect cells grafted in the hearts.
RESULTS: One month after transplantation, left ventricular ejection fraction decreased by 8 ± 4% in controls, whereas it increased by 7 ± 3% in CD133+-grafted hearts (p = 0.0015 vs. controls) and further by 15 ± 5% in SM-treated hearts (p = 0.008 vs. controls). Systolic indices yielded by pressure-volume loops paralleled these data. Engrafted myotubes were identified in all SM-treated hearts by immunofluorescence, whereas in CD133+-grafted hearts, few human cells were only detected by polymerase chain reaction.
CONCLUSIONS: In the setting of postinfarction scars, the transplantation of bone marrow-derived CD133+ progenitors improves cardiac function, but this benefit is not superior to that afforded by myogenic cells.
|
Abbreviations and Acronyms
| | FACS | = fluorescence-activated cell sorting | | HLA | = human leukocyte antigen | | LVEF | = left ventricular ejection fraction | | LV | = left ventricular | | mAb | = monoclonal antibody | | MyHC | = myosin heavy chain | | pAb | = polyclonal antibody | | PCR | = polymerase chain reaction | | SM | = skeletal myoblast |
|
This article has been cited by other articles:
|
|
|
|
 
G. Kania, P. Blyszczuk, S. Stein, A. Valaperti, D. Germano, S. Dirnhofer, L. Hunziker, C. M. Matter, and U. Eriksson
Heart-Infiltrating Prominin-1+/CD133+ Progenitor Cells Represent the Cellular Source of Transforming Growth Factor {beta}-Mediated Cardiac Fibrosis in Experimental Autoimmune Myocarditis
Circ. Res.,
August 28, 2009;
105(5):
462 - 470.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L Kao, W. Browder, and C. Li
Cellular Cardiomyoplasty: What Have We Learned?
Asian Cardiovasc Thorac Ann,
January 1, 2009;
17(1):
89 - 101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Perez-Ilzarbe, O. Agbulut, B. Pelacho, C. Ciorba, E. S. Jose-Eneriz, M. Desnos, A. A. Hagege, P. Aranda, E. J. Andreu, P. Menasche, et al.
Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium
Eur J Heart Fail,
November 1, 2008;
10(11):
1065 - 1072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Arbab, B. Janic, R. A. Knight, S. A. Anderson, E. Pawelczyk, A. M. Rad, E. J. Read, S. D. Pandit, and J. A. Frank
Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings
FASEB J,
September 1, 2008;
22(9):
3234 - 3246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Hassink, K. B. Pasumarthi, H. Nakajima, M. Rubart, M. H. Soonpaa, A. B. de la Riviere, P. A. Doevendans, and L. J. Field
Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction
Cardiovasc Res,
April 1, 2008;
78(1):
18 - 25.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Shujia, H. K. Haider, N. M. Idris, G. Lu, and M. Ashraf
Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair
Cardiovasc Res,
February 1, 2008;
77(3):
525 - 533.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Suuronen, J. Price, J. P. Veinot, K. Ascah, V. Kapila, X.-W. Guo, S. Wong, T. G. Mesana, and M. Ruel
Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function.
J. Thorac. Cardiovasc. Surg.,
November 1, 2007;
134(5):
1249 - 1258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Leor, S. Gerecht, S. Cohen, L. Miller, R. Holbova, A. Ziskind, M. Shachar, M. S Feinberg, E. Guetta, and J. Itskovitz-Eldor
Human embryonic stem cell transplantation to repair the infarcted myocardium
Heart,
October 1, 2007;
93(10):
1278 - 1284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Khan, V. K. Kutala, D. S. Vikram, S. Wisel, S. M. Chacko, M. L. Kuppusamy, I. K. Mohan, J. L. Zweier, P. Kwiatkowski, and P. Kuppusamy
Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function
Am J Physiol Heart Circ Physiol,
October 1, 2007;
293(4):
H2129 - H2139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Amsalem, Y. Mardor, M. S. Feinberg, N. Landa, L. Miller, D. Daniels, A. Ocherashvilli, R. Holbova, O. Yosef, I. M. Barbash, et al.
Iron-Oxide Labeling and Outcome of Transplanted Mesenchymal Stem Cells in the Infarcted Myocardium
Circulation,
September 11, 2007;
116(11_suppl):
I-38 - I-45.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Breitbach, T. Bostani, W. Roell, Y. Xia, O. Dewald, J. M. Nygren, J. W. U. Fries, K. Tiemann, H. Bohlen, J. Hescheler, et al.
Potential risks of bone marrow cell transplantation into infarcted hearts
Blood,
August 15, 2007;
110(4):
1362 - 1369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. K. Sim, L. Ye, and H. K. Haider
New Strategy for Cardiac Repair: Genetically Modified Skeletal Myoblasts
Asian Cardiovasc Thorac Ann,
June 1, 2007;
15(3):
183 - 184.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Bonaros, R. Rauf, D. Wolf, E. Margreiter, A. Tzankov, B. Schlechta, A. Kocher, H. Ott, T. Schachner, S. Hering, et al.
Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure
J. Thorac. Cardiovasc. Surg.,
December 1, 2006;
132(6):
1321 - 1328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Perin and G. V. Silva
Stem cell therapy in end-stage ischaemic heart failure: a catheter-based therapeutic strategy targeting myocardial viability
Eur. Heart J. Suppl.,
December 1, 2006;
8(suppl_H):
H46 - H51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Agbulut, M. Mazo, C. Bressolle, M. Gutierrez, K. Azarnoush, L. Sabbah, N. Niederlander, G. Abizanda, E. J. Andreu, B. Pelacho, et al.
Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium?
Cardiovasc Res,
October 1, 2006;
72(1):
175 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Suuronen, J. P. Veinot, S. Wong, V. Kapila, J. Price, M. Griffith, T. G. Mesana, and M. Ruel
Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood
Circulation,
July 4, 2006;
114(1_suppl):
I-138 - I-144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ma, Y. Ladilov, J. M. Moebius, L. Ong, C. Piechaczek, A. David, A. Kaminski, Y.-H. Choi, W. Li, D. Egger, et al.
Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells
Cardiovasc Res,
July 1, 2006;
71(1):
158 - 169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Dimarakis, N. A. Habib, and M. Y.A. Gordon
Adult bone marrow-derived stem cells and the injured heart: just the beginning?
Eur. J. Cardiothorac. Surg.,
November 1, 2005;
28(5):
665 - 676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Bartunek, M. Vanderheyden, B. Vandekerckhove, S. Mansour, B. De Bruyne, P. De Bondt, I. Van Haute, N. Lootens, G. Heyndrickx, and W. Wijns
Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety
Circulation,
August 30, 2005;
112(9_suppl):
I-178 - I-183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Siepe, C. Heilmann, P. von Samson, P. Menasche, and F. Beyersdorf
Stem cell research and cell transplantation for myocardial regeneration
Eur. J. Cardiothorac. Surg.,
August 1, 2005;
28(2):
318 - 324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Dudley Jr
Beware of Cells Bearing Gifts: Cell Replacement Therapy and Arrhythmic Risk
Circ. Res.,
July 22, 2005;
97(2):
99 - 101.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Dai, S. L. Hale, B. J. Martin, J.-Q. Kuang, J. S. Dow, L. E. Wold, and R. A. Kloner
Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium: Short- and Long-Term Effects
Circulation,
July 12, 2005;
112(2):
214 - 223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. Wollert and H. Drexler
Clinical Applications of Stem Cells for the Heart
Circ. Res.,
February 4, 2005;
96(2):
151 - 163.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
137 - 153.
[Full Text]
[PDF]
|
|
|
|
